וידאזה
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
AZACITIDINE 100 MG
Available from:
NEOPHARM LTD
ATC code:
L01BC07
Pharmaceutical form:
LYOPHILIZED POWDER FOR SUSPENSION FOR INJECTION
Administration route:
I.V, S.C
Manufactured by:
CELGENE INTERNATIONAL SARL, SWITZERLAND
Therapeutic group:
AZACITIDINE
Therapeutic indications:
For the treatment of patients with the following myelodysplastic syndromes subtypes: refractory anemia or refractory anemia with ringed sideroblasts ( if accompanied by neutropenia or thrombocytopenia or requiring transfusions),refractory anaemia with excess blasts, refractory anaemia with excess blasts in transformation, and chronic myelomonocytic leukaema.
Authorization date:
2012-12-01
